A marked reduction in colorectal cancer recurrence after surgery has led investigators to wonder whether some patients can skip intensive surveillance afterward.
Access to care for the highly preventable disease is thought to be behind why Black Americans are 20% more likely to receive a colorectal cancer diagnosis than any other racial or ethnic group.
Researchers used a large national database to compare risk of all types of GI cancers associated with popular drug classes used to treat type 2 diabetes.